Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...
MIT researchers have dramatically lowered the error rate of prime editing, a technique with promise for treating numerous ...
AstraZeneca has signed a $555 million deal with a San Francisco-based biotech business Algen Biotechnologies, The Financial Times reported on Monday.
MedPage Today on MSN
Gene-Editing Therapy Promising for Rare Hereditary Disease
A gene-editing therapy led to durable changes in serum transthyretin levels among people with hereditary transthyretin ...
CRISPR Therapeutics has developed SyNTase editing, a proprietary, next-generation, site-specific gene correction platform.
Amazon S3 on MSN
CRISPR: The Future of Gene Editing and Disease Treatment
Have you ever looked into the face of evil? Today, we’re taking a horrifying journey into the depths of the worst of humanity ...
G lobal pharmaceutical giant AstraZeneca has penned a $555 million with Algen Biotechnologies, a San Francisco-based ...
Founded in 2020 by Chilean biochemist Bernardo Pollak, Meristem is using precise gene editing techniques to develop local ...
Jennifer Doudna helped discover the gene editing technology CRISPR and has made many contributions to our knowledge of RNA chemistry. Credit: Laura Morton For Doudna, the Priestley Medal is the latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback